Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Type-A for Myofascial Pain Syndrome
NCT06899438Completed
- Sponsor
- Bursa City Hospital
- Start
- Aug 2009
- Primary completion
- Jan 2010
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Randomised trial of botulinum toxin type A in myofascial pain syndrome (MPS) (2 arms), sponsored by Bursa City Hospital. Primary endpoints: Visual Analog Scale at 6 weeks, 4-Point Verbal Rating Scale at 6 weeks and 1 more. Started Aug 2009; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
myofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT06899438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06899438.